Results 71 to 80 of about 5,034 (114)

Treatment outcomes in 63 cases of juvenile dermatomyositis-associated calcinosis. [PDF]

Clin Exp Rheumatol
Yi BY, Wahezi DM, Covert L, Ardalan K, Hui-Yuen J, Vasquez-Canizares N, Mosa DM, Jones M, Correll C, Begezda A, Shenoi S, Wu EY, Kovalick LK, Lapin WB, Tarvin SE, Oliver MS, Rodriguez MM, Marmor I, Baszis KW, Taxter AJ, Hanson AC, Crowson CS, Orandi AB, CARRA Juvenile Dermatomyositis, Calcinosis Subcommittee.   +24 more
europepmc   +1 more source

Juvenile Dermatomyositis and Hepatitis B Viral Infection. [PDF]

Eur J Case Rep Intern Med
Younis AA, Ahmed Al-Harbi AA.
europepmc   +1 more source

Long-term outcome of juvenile dermatomyositis associated with lipodystrophy: experience of a University hospital. [PDF]

An Bras Dermatol
Kapetanović I, Gajić-Veljić M, Bonači-Nikolić B, Nikolić M.   +3 more
europepmc   +1 more source

Application of HRCT-based radiomics to predict interstitial lung disease for juvenile dermatomyositis. [PDF]

BMC Pediatr
Liu L, Hu M, Zhou Y, Zheng F, Ma X, Yang L, Xu Y, Teng L, Hu B, Lu M, Xu X.   +10 more
europepmc   +1 more source

Approach to Janus kinase inhibition for juvenile dermatomyositis among CARRA and PReS providers. [PDF]

Rheumatology (Oxford)
Sherman MA, Nicolai R, Datyner EK, Rosina S, Hamilton A, Ardalan K, Bader-Meunier B, Brown AG, Jansen MHA, Kim S, Lang B, Campanilho-Marques R, McCann LJ, Sanner H, Veldkamp SR, Wilkinson MGL, Yi BY, Kim H, Tarvin SE, Papadopoulou C, CARRA JDM Therapeutics Workgroup and the PReS JDM Working Party .   +20 more
europepmc   +1 more source

Tofacitinib monotherapy as maintenance treatment in juvenile dermatomyositis: a case report. [PDF]

RMD Open
Argüelles Balas D, Barral Mena E, Martín Díaz MÁ, Calvo-Aranda E.   +3 more
europepmc   +1 more source

Juvenile dermatomyositis in Oman: clinical patterns and disease trajectory from a National cohort. [PDF]

Pediatr Rheumatol Online J
Abdwani R, Mal MJ, Al Masroori E, Al Jashmi R, Abrawi SA, Al-Zakwani I.   +5 more
europepmc   +1 more source

Physical Growth Dynamics of Children With Juvenile Dermatomyositis. [PDF]

Cureus
Soni K, Kaur H, Gupta A, Singh S, Saha SC, Bhalla A.   +5 more
europepmc   +1 more source

Tofacitinib: a promising agent for the treatment of persistent rashes in juvenile dermatomyositis. [PDF]

World J Pediatr
Chen ZY, Zhang TN, Li J, Zhang ZJ, Song HM.   +4 more
europepmc   +1 more source

Anti-TIF1-Gamma Autoantibodies-Positive Juvenile Dermatomyositis Associated With Interstitial Lung Disease: A Case Report. [PDF]

Cureus
Cid-Puente R, Carreon-Meza IA, Herrera-VanOostdam DA.   +2 more
europepmc   +1 more source